ECAT
Overvalued by 99.8% based on the discounted cash flow analysis.
Market cap | $1.82 Billion |
---|---|
Enterprise Value | $1.82 Billion |
Dividend Yield | $1.5 (12.9963066592054%) |
Earnings per Share | $2.71 |
Beta | 0 |
Outstanding Shares | - |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 6.61 |
---|---|
PEG | - |
Price to Sales | - |
Price to Book Ratio | - |
Enterprise Value to Revenue | - |
Enterprise Value to EBIT | - |
Enterprise Value to Net Income | - |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data